Tejnaksh Healthcare Ltd. IPO
IPO Timeline
Category-wise Subscription
| Category | Sub (x) | Offered | Bid For | Amt (Cr)* |
|---|---|---|---|---|
| NII (HNI) | — | 144,000 (47%) | — | ₹115 Cr |
| Retail | — | 144,000 (47%) | — | ₹115 Cr |
| Market Maker | — | 16,000 (5%) | — | ₹1 Cr |
| Σ Total | — | 304,000 (100%) | — | ₹2,432 Cr |
Only available investor categories are shown. Amount is auto-calculated when shares offered and issue price are available.
Issue Details
Minimum Investment (Lot-wise)
| Category | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 1 | 1,600 | ₹128,000 |
| Retail (Max) | 13 | 20,800 | ₹1,664,000 |
| S-HNI (Min) | 14 | 22,400 | ₹1,792,000 |
| B-HNI (Min) | 67 | 107,200 | ₹8,576,000 |
Valuation & Key Ratios
Grey Market Premium (GMP)
GMP is an unofficial grey market indicator and does not guarantee actual listing price. Invest at your own risk.
Objects of the Issue
- 1 Expansion and Development of Hospital of the Company – 1.50
- 2 General Corporate purposes – 0.60
- 3 Issue Expenses – 0.33
Company Overview
Incorporated in 2008, Tejnaksh Healthcare run an Institute of Urology, an ISO certified the international level Urology hospital. The 24000 Sq. Ft. campus has a four storey building which houses the complete Urology setup. It provides a comprehensive range of services from consultations and investigations to treatment for Urology.
Tejnaksh Healthcare is equipped with all latest equipment and provide the whole range of services. The Institute is recognized by National board of examinations for DNB (Urology). The Institute boasts of 150 research publications and 23 innovations.
Tejnaksh Healthcare is an integrated healthcare delivery service provider, committed to delivering quality healthcare services to our patients in modern facilities. Company's operations are divided across four key vertical streams in healthcare delivery, namely - Pediatric Urology, Adult Urology (Male, Female), Andrology and Sexual Dysfunction and Nephrology, Dialysis and Renal Transplant.